Search Clinical Trials
596,361 trials
ID
Status
Phase
Title
Sponsor
NCT07739953
Development and Clinical Application of ApoC3 Protein as a Predictive Biomarker for Insulin Resistance in Polycystic Ovary SyndromeGuangdong Women and Children HospitalActive Not Recruiting
NCT07739953Active Not Recruiting
—
Development and Clinical Application of ApoC3 Protein as a Predictive Biomarker...Guangdong Women and Child...
NCT07739342
Evaluating the Occurrence of DKA in People With Type I DiabetesAbbott Diabetes CareNot Yet Recruiting
NCT07739342Not Yet Recruiting
—
Evaluating the Occurrence of DKA in People With Type I DiabetesAbbott Diabetes Care
NCT07738367
Bronchial Artery Chemoembolization (BACE) Combination Therapy for Advanced NSCLCFujian Cancer HospitalEnrolling By InvitationPhase 2
NCT07738367Enrolling By Invitation
Phase 2
Bronchial Artery Chemoembolization (BACE) Combination Therapy for Advanced NSCLCFujian Cancer Hospital
NCT07739199
A Study Comparing BL-B01D1 in Combination With PD-1/VEGF Bispecific Antibody Versus Chemotherapy in Combination With PD-1/VEGF Bispecific Antibody in First-line Patients With Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer(PANKU-Lung05)Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Not Yet RecruitingPhase 2
NCT07739199Not Yet Recruiting
Phase 2
A Study Comparing BL-B01D1 in Combination With PD-1/VEGF Bispecific Antibody Ver...Baili-Bio (Chengdu) Pharm...
NCT07739823
Validation of a Wireless Wearable Vital Signs Monitor in Pediatric PatientMcGill University Health Centre/Research Institute of the McGill University Health CentreNot Yet Recruiting
NCT07739823Not Yet Recruiting
—
Validation of a Wireless Wearable Vital Signs Monitor in Pediatric PatientMcGill University Health...
NCT07739186
A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody Versus Tislelizumab Plus Platinum-doublet Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer(PANKU-Lung06)Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Not Yet RecruitingPhase 2
NCT07739186Not Yet Recruiting
Phase 2
A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody...Baili-Bio (Chengdu) Pharm...
NCT07739056
Neural, Cognitive, and Biomechanical Determinants of Falls in Older AdultsUniversity of SharjahNot Yet RecruitingNot Applicable
NCT07739056Not Yet Recruiting
Not Applicable
Neural, Cognitive, and Biomechanical Determinants of Falls in Older AdultsUniversity of Sharjah
NCT07739030
Prehospital and Acute Phase Characteristics of Severe Spontaneous ICHKirsten MollerCompleted
NCT07739030Completed
—
Prehospital and Acute Phase Characteristics of Severe Spontaneous ICHKirsten Moller
NCT07739784
This Study Examines Whether Personality Traits Influence the Frequency or Severity of Ocular Adverse Effects Reported by Patients Using Glaucoma Medications. The Findings May Identify Patients at Greater Risk of Intolerance and Support More Personalized Treatment and Counselling.McGill University Health Centre/Research Institute of the McGill University Health CentreRecruiting
NCT07739784Recruiting
—
This Study Examines Whether Personality Traits Influence the Frequency or Severi...McGill University Health...
NCT07739719
SAFE (Self-Administration of Flumist to ImprovE Uptake: A Household-Based Cluster Randomized Trial)McMaster UniversityNot Yet RecruitingPhase 4
NCT07739719Not Yet Recruiting
Phase 4
SAFE (Self-Administration of Flumist to ImprovE Uptake: A Household-Based Cluste...McMaster University
NCT07739927
Serrated Inferior Turbinate Variation and Sinonasal Findings on CBCTRecep Tayyip Erdogan University Training and Research HospitalNot Yet Recruiting
NCT07739927Not Yet Recruiting
—
Serrated Inferior Turbinate Variation and Sinonasal Findings on CBCTRecep Tayyip Erdogan Univ...
NCT07740564
Phase III Study of OT202 in Treating Moderate to Severe Dry EyeOcumension Therapeutics (Suzhou) Co., LtdNot Yet RecruitingPhase 3
NCT07740564Not Yet Recruiting
Phase 3
Phase III Study of OT202 in Treating Moderate to Severe Dry EyeOcumension Therapeutics (...
NCT07738822
A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wAIHACullinan Therapeutics Inc.Not Yet RecruitingPhase 1
NCT07738822Not Yet Recruiting
Phase 1
A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wA...Cullinan Therapeutics Inc...
NCT07739992
Dose Optimization Study of Acute Intermittent Hypoxia in Spinal Cord InjuryMilap SandhuRecruitingNot Applicable
NCT07739992Recruiting
Not Applicable
Dose Optimization Study of Acute Intermittent Hypoxia in Spinal Cord InjuryMilap Sandhu
NCT07739173
Multicomponent Versus Balance Exercise for Older Adults With Recurrent FallsBalikesir UniversityCompletedNot Applicable
NCT07739173Completed
Not Applicable
Multicomponent Versus Balance Exercise for Older Adults With Recurrent FallsBalikesir University
NCT07740499
TOLerogenic Potential of Hematopoietic Stem and Progenitor Cells and Inflammatory Bowel DiseaseIRCCS San RaffaeleNot Yet Recruiting
NCT07740499Not Yet Recruiting
—
TOLerogenic Potential of Hematopoietic Stem and Progenitor Cells and Inflammator...IRCCS San Raffaele
NCT07739498
Posterior Resin Bite Turbos Effect on Maxillary Expansion Using a HYRAX Expander in Early AdolescentsMansoura UniversityRecruitingNot Applicable
NCT07739498Recruiting
Not Applicable
Posterior Resin Bite Turbos Effect on Maxillary Expansion Using a HYRAX Expander...Mansoura University
NCT07739472
Mobile Application-Supported Education in Nursing StudentsMaltepe UniversityCompletedNot Applicable
NCT07739472Completed
Not Applicable
Mobile Application-Supported Education in Nursing StudentsMaltepe University
NCT07739771
Retrospective Observational Study of Oral Complications and Quality of Life in Head and Neck Cancer Patients Treated With Radiotherapy or Chemoradiotherapy.Clínica VilaboaNot Yet Recruiting
NCT07739771Not Yet Recruiting
—
Retrospective Observational Study of Oral Complications and Quality of Life in H...Clínica Vilaboa
Result Breakdown
Not yet recruiting11 (55%)
Completed4 (20%)
Recruiting3 (15%)
Active, not recruiting1 (5%)
Enrolling by invitation1 (5%)
Not Specified8 (40%)
not_applicable5 (25%)
Phase 23 (15%)
Phase 32 (10%)
Phase 41 (5%)
Phase 11 (5%)